-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $49

Benzinga·10/29/2026 11:11:44
语音播报
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $56 to $49.